Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PROTOVES-M1
- Development stage
- Unknown
- Lead developer
- Bio-STILOGIT Pharmaceuticals
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
PROTOVES-M1 is a multi-ingredient dietary supplement developed by Bio-STILOGIT Pharmaceuticals, primarily indicated for the maintenance of prostate health and the management of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). The formulation typically contains a synergistic combination of botanical extracts and minerals, including *Serenoa repens* (Saw Palmetto), *Urtica dioica* (Nettle), and *Boswellia serrata*, alongside antioxidants such as Lycopene, Zinc, and Selenium. These ingredients work together to provide anti-inflammatory, antioxidant, and anti-androgenic effects, specifically through the inhibition of 5-alpha-reductase and 5-lipoxygenase (5-LOX) pathways. It is marketed as a retail consumer product in Italy.
- Brand names
- PROTOVES-M1PROTOVES-M-1PROTOVES-M 1
02
Targets
Steroidogenesis (Steroidogenic enzymes)AR (Adrenergic receptors)Eicosanoid synth (Eicosanoid biosynthesis)SHBG (Sex hormone-binding globulin)
Beyond the preview
Go deeper on PROTOVES-M1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PROTOVES-M1.